Scioto Biosciences

Preclinical stage company developing innovative therapies devoted to having a transformative impact.

Launch date

2017

Employees

Market cap

Enterprise valuation

Indianapolis Indiana (HQ)

Date	Investors	Amount	Round
-	VisionTech Partners Pathway Bioventures Small Business Innovation Research (SBIR) Michigan Capital Network	N/A	-
May 2017	National Institutes of Health	$330k	Grant
May 2018	BioCrossroads Rev1 Ventures Elevate Ventures	$1.8m	Series A
Aug 2019	National Institutes of Health	$2.3m	Grant
Aug 2020	Genome Company	$26.5m	Series B
Total Funding		€28.1m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Scioto Biosciences